Sotera Health Announces First-Quarter 2026 Earnings Release Date
Rhea-AI Summary
Sotera Health (Nasdaq: SHC) will release first-quarter 2026 results for the period ended March 31, 2026 before market open on Tuesday, May 5, 2026. Management will hold a conference call at 9:00 a.m. Eastern Daylight Time the same day to discuss operating and financial results.
A live webcast and accompanying materials will be available via the Investor Relations section of the company website, with a replay posted later on May 5. Updates on recent investor matters and Ethylene Oxide developments are published on the Investor Relations site.
Positive
- None.
Negative
- None.
News Market Reaction – SHC
In the Apr 21 session, SHC declined 1.90%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 17 | Earnings release timing | Neutral | -0.2% | Announced Q4 and full-year 2025 results date and conference call logistics. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date news saw a small move of -0.18%, suggesting typically muted reactions to scheduling updates.
Over recent months, Sotera Health news included board changes, a large shareholder secondary offering, and full-year 2025 results with 20 years of revenue growth and outlook for 2026. For the same earnings date tag, the company previously scheduled its Q4 and full-year 2025 release before market open with a 9:00 a.m. call, which drew only a -0.18% move, indicating these timing announcements have had limited price impact.
Key Terms
ethylene oxide medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2026 before the market opens on Tuesday, May 5, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s operating and financial results.
A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available later in the day on May 5.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
| Contacts |
| Jason Peterson Vice President, Investor Relations IR@soterahealth.com |
| Kristin Gibbs Chief Marketing Officer, Sotera Health kgibbs@soterahealth.com |
Source: Sotera Health Company